Humana Files 8-K on Operations & Financial Condition

TL;DR

**Humana just dropped an 8-K on financial results, get ready for potential stock movement.**

AI Summary

Humana Inc. filed an 8-K on January 25, 2024, to report on its results of operations and financial condition, as well as to make a Regulation FD disclosure. This filing indicates that Humana is providing updated financial information to the public, which is crucial for investors to understand the company's current performance and future outlook. For shareholders, this means new data is available that could influence the stock's valuation and their investment decisions.

Why It Matters

This filing provides investors with the latest financial health update from Humana Inc., which can directly impact stock price and future investment sentiment.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial information and does not inherently signal high risk, though the content of the disclosed financial results could be positive or negative.

Analyst Insight

Investors should review the full content of the financial results and Regulation FD disclosure once available to understand the specific impacts on Humana's performance and future outlook.

Key Players & Entities

• Humana Inc. (company) — the registrant filing the 8-K
• January 25, 2024 (date) — date of earliest event reported and filing date
• 500 West Main Street, Louisville, KY 40202 (address) — principal executive offices of Humana Inc.
• 1-5975 (number) — Commission File Number for Humana Inc.
• 61-0647538 (number) — IRS Employer Identification No. for Humana Inc.

FAQ

From the Filing

0000049071-24-000007.txt : 20240125 0000049071-24-000007.hdr.sgml : 20240125 20240125063533 ACCESSION NUMBER: 0000049071-24-000007 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20240125 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240125 DATE AS OF CHANGE: 20240125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANA INC CENTRAL INDEX KEY: 0000049071 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 610647538 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05975 FILM NUMBER: 24558512 BUSINESS ADDRESS: STREET 1: 500 W MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 BUSINESS PHONE: 5025801000 MAIL ADDRESS: STREET 1: 500 W. MAIN ST CITY: LOUISVILLE STATE: KY ZIP: 40202 FORMER COMPANY: FORMER CONFORMED NAME: EXTENDICARE INC DATE OF NAME CHANGE: 19740404 FORMER COMPANY: FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC DATE OF NAME CHANGE: 19671129 8-K 1 hum-20240125.htm 8-K hum-20240125 0000049071 false 0000049071 2024-01-25 2024-01-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K                  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported):  January 25, 2024 (January 25, 2024) Humana Inc. (Exact name of registrant as specified in its charter) Delaware 1-5975 61-0647538 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 500 West Main Street Louisville , KY 40202 (Address of principal executive offices, including zip code) 502 - 580-1000 (Registrant’s telephone number, including area code) (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock HUM New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ Item 2.02    Results of Operations and Financial Condition. Item 7.01    Regulation FD Disclosure. Humana Inc. (the "Company") issued a press release this morning reporting financial results for the quarter ended December 31, 2023, and posted a detailed earnings release related to the same period to the Investor Relations portion of the Company’s website at www.humana.com . A copy of each release is attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and each release is